Green Monday is working on a plant-based alternative to pork and has raised the money from investors including Swire Pacific and returning backer Lee Kum Kee Health Products.

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.

Sesame Workshop's online education portfolio company has raised fresh funding to seize on higher demand during the coronavirus pandemic.

Precision cancer drug developer Novellus boosted its funding total to $75.5m with a round featuring SR One and Novartis Venture Fund.

The Kunlun-backed customer engagement software provider has closed its series C round at about $44m, having raised a similar amount in series C1 funding four months ago.

Telkom Indonesia and Go-Jek have thrown their weight behind Mobile Premier League’s latest funding round that will allow the esports platform to expand outside of India.

SymBiosis and Susquehanna International Group were among a consortium of new and existing backers that supplied $90m in series D financing to Finch Therapeutics.

Tencent has led a $64m series D round for the healthtech developer, whose shareholders already include SoftBank.

Novo Ventures and Sanofi Ventures co-led a series C round for the cancer therapy developer, which builds on work at Amsterdam UMC.